Evidence map›Paper›PMID 28821775›Full record

ArticleScientific reports2017

ATF3 negatively regulates cellular antiviral signaling and autophagy in the absence of type I interferons.

Vikas Sood, Kiran Bala Sharma, Vishal Gupta, Dhurjhoti Saha, Parashar Dhapola, Manish Sharma, Utsav Sen, Shigetaka Kitajima, Shantanu Chowdhury, Manjula Kalia and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Ebola virus exploits host lncRNAbioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Classification and regulatory interactions of key transcription factors in COVID-19.Frontiers in cellular and infection microbiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Transcriptomic response of lumpfish (Frontiers in immunology · 2024
    Article
  16. Article
  17. Japanese Encephalitis Virus-Infected Cells.Sub-cellular biochemistry · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Vikas SoodVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India. vikas@thsti.res.in.
Kiran Bala SharmaVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India.
Vishal GuptaVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India.
Dhurjhoti SahaCSIR-Institute of Genomics and Integrative Biology, Delhi, 110007, India.
Parashar DhapolaCSIR-Institute of Genomics and Integrative Biology, Delhi, 110007, India.
Manish SharmaVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India.
Utsav SenVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India.
Shigetaka KitajimaTokyo Medical and Dental University, Tokyo, 113-0034, Japan.
Shantanu ChowdhuryCSIR-Institute of Genomics and Integrative Biology, Delhi, 110007, India.
Manjula KaliaVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India.ORCID 0000-0002-3376-3659
Sudhanshu VratiVaccine and Infectious Disease Research Centre, Translational Health Science and Technology Institute, Faridabad, 121001, India. vrati@thsti.res.in.
Translational Health Science and Technology Institute · INInstitute of Genomics and Integrative Biology · INTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stringent regulation of antiviral signaling and cellular autophagy is critical for the host response to virus infection. However, little is known how these cellular processes are regulated in the absence of type I interferon signaling. Here, we show that ATF3 is induced following Japanese encephalitis virus (JEV) infection, and regulates cellular antiviral and autophagy pathways in the absence of type I interferons in mouse neuronal cells. We have identified new targets of ATF3 and show that it binds to the promoter regions of Stat1, Irf9, Isg15 and Atg5 thereby inhibiting cellular antiviral signaling and autophagy. Consistent with these observations, ATF3-depleted cells showed enhanced antiviral responses and induction of robust autophagy. Furthermore, we show that JEV replication was significantly reduced in ATF3-depleted cells. Our findings identify ATF3 as a negative regulator of antiviral signaling and cellular autophagy in mammalian cells, and demonstrate its important role in JEV life cycle.

Indexed as

AutophagyEncephalitis Virus, JapaneseSignal TransductionActivating Transcription Factor 3AnimalsCell LineEncephalitis, JapaneseGene Expression RegulationHost-Pathogen InteractionsHumansInterferon-Stimulated Gene Factor 3, gamma SubunitInterferon Type IMicePromoter Regions, GeneticProtein BindingSTAT Transcription FactorsActivating Transcription Factor 3Atf3 protein, mouseInterferon-Stimulated Gene Factor 3, gamma SubunitInterferon Type ISTAT Transcription Factors

Identifiers

PMID28821775
PMCPMC5562757
OpenAlexW2747112099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.